Bausch + Lomb Corporation (BLCO)

Market Cap	4.98B
Revenue (ttm)	4.79B
Net Income (ttm)	-317.00M
Shares Out	352.47M
EPS (ttm)	-0.90
PE Ratio	n/a
Forward PE	21.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,788,246
Open	14.66
Previous Close	15.00
Day's Range	13.88 - 14.66
52-Week Range	13.16 - 21.69
Beta	0.49
Analysts	Hold
Price Target	19.10 (+35.17%)
Earnings Date	Apr 30, 2025

About BLCO

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provides optical correction during heal...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 6, 2022
• Employees: 13,300
• Stock Exchange: NYSE
• Ticker Symbol: BLCO
• Website: https://www.bausch.com

Financial Performance

In 2024, Bausch + Lomb's revenue was $4.79 billion, an increase of 15.56% compared to the previous year's $4.15 billion. Losses were -$317.00 million, 21.9% more than in 2023.

Analyst Forecast

According to 11 analysts, the average rating for BLCO stock is "Hold." The 12-month stock price forecast is $19.1, which is an increase of 35.17% from the latest price.

Price Target

$19.1

(35.17% upside)

Analyst Consensus: Hold